Cargando…

Dysregulated Signaling at Postsynaptic Density: A Systematic Review and Translational Appraisal for the Pathophysiology, Clinics, and Antipsychotics’ Treatment of Schizophrenia

Emerging evidence from genomics, post-mortem, and preclinical studies point to a potential dysregulation of molecular signaling at postsynaptic density (PSD) in schizophrenia pathophysiology. The PSD that identifies the archetypal asymmetric synapse is a structure of approximately 300 nm in diameter...

Descripción completa

Detalles Bibliográficos
Autores principales: de Bartolomeis, Andrea, Vellucci, Licia, De Simone, Giuseppe, Mazza, Benedetta, Barone, Annarita, Ciccarelli, Mariateresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954794/
https://www.ncbi.nlm.nih.gov/pubmed/36831241
http://dx.doi.org/10.3390/cells12040574
_version_ 1784894201205358592
author de Bartolomeis, Andrea
Vellucci, Licia
De Simone, Giuseppe
Mazza, Benedetta
Barone, Annarita
Ciccarelli, Mariateresa
author_facet de Bartolomeis, Andrea
Vellucci, Licia
De Simone, Giuseppe
Mazza, Benedetta
Barone, Annarita
Ciccarelli, Mariateresa
author_sort de Bartolomeis, Andrea
collection PubMed
description Emerging evidence from genomics, post-mortem, and preclinical studies point to a potential dysregulation of molecular signaling at postsynaptic density (PSD) in schizophrenia pathophysiology. The PSD that identifies the archetypal asymmetric synapse is a structure of approximately 300 nm in diameter, localized behind the neuronal membrane in the glutamatergic synapse, and constituted by more than 1000 proteins, including receptors, adaptors, kinases, and scaffold proteins. Furthermore, using FASS (fluorescence-activated synaptosome sorting) techniques, glutamatergic synaptosomes were isolated at around 70 nm, where the receptors anchored to the PSD proteins can diffuse laterally along the PSD and were stabilized by scaffold proteins in nanodomains of 50–80 nm at a distance of 20–40 nm creating “nanocolumns” within the synaptic button. In this context, PSD was envisioned as a multimodal hub integrating multiple signaling-related intracellular functions. Dysfunctions of glutamate signaling have been postulated in schizophrenia, starting from the glutamate receptor’s interaction with scaffolding proteins involved in the N-methyl-D-aspartate receptor (NMDAR). Despite the emerging role of PSD proteins in behavioral disorders, there is currently no systematic review that integrates preclinical and clinical findings addressing dysregulated PSD signaling and translational implications for antipsychotic treatment in the aberrant postsynaptic function context. Here we reviewed a critical appraisal of the role of dysregulated PSD proteins signaling in the pathophysiology of schizophrenia, discussing how antipsychotics may affect PSD structures and synaptic plasticity in brain regions relevant to psychosis.
format Online
Article
Text
id pubmed-9954794
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99547942023-02-25 Dysregulated Signaling at Postsynaptic Density: A Systematic Review and Translational Appraisal for the Pathophysiology, Clinics, and Antipsychotics’ Treatment of Schizophrenia de Bartolomeis, Andrea Vellucci, Licia De Simone, Giuseppe Mazza, Benedetta Barone, Annarita Ciccarelli, Mariateresa Cells Systematic Review Emerging evidence from genomics, post-mortem, and preclinical studies point to a potential dysregulation of molecular signaling at postsynaptic density (PSD) in schizophrenia pathophysiology. The PSD that identifies the archetypal asymmetric synapse is a structure of approximately 300 nm in diameter, localized behind the neuronal membrane in the glutamatergic synapse, and constituted by more than 1000 proteins, including receptors, adaptors, kinases, and scaffold proteins. Furthermore, using FASS (fluorescence-activated synaptosome sorting) techniques, glutamatergic synaptosomes were isolated at around 70 nm, where the receptors anchored to the PSD proteins can diffuse laterally along the PSD and were stabilized by scaffold proteins in nanodomains of 50–80 nm at a distance of 20–40 nm creating “nanocolumns” within the synaptic button. In this context, PSD was envisioned as a multimodal hub integrating multiple signaling-related intracellular functions. Dysfunctions of glutamate signaling have been postulated in schizophrenia, starting from the glutamate receptor’s interaction with scaffolding proteins involved in the N-methyl-D-aspartate receptor (NMDAR). Despite the emerging role of PSD proteins in behavioral disorders, there is currently no systematic review that integrates preclinical and clinical findings addressing dysregulated PSD signaling and translational implications for antipsychotic treatment in the aberrant postsynaptic function context. Here we reviewed a critical appraisal of the role of dysregulated PSD proteins signaling in the pathophysiology of schizophrenia, discussing how antipsychotics may affect PSD structures and synaptic plasticity in brain regions relevant to psychosis. MDPI 2023-02-10 /pmc/articles/PMC9954794/ /pubmed/36831241 http://dx.doi.org/10.3390/cells12040574 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Systematic Review
de Bartolomeis, Andrea
Vellucci, Licia
De Simone, Giuseppe
Mazza, Benedetta
Barone, Annarita
Ciccarelli, Mariateresa
Dysregulated Signaling at Postsynaptic Density: A Systematic Review and Translational Appraisal for the Pathophysiology, Clinics, and Antipsychotics’ Treatment of Schizophrenia
title Dysregulated Signaling at Postsynaptic Density: A Systematic Review and Translational Appraisal for the Pathophysiology, Clinics, and Antipsychotics’ Treatment of Schizophrenia
title_full Dysregulated Signaling at Postsynaptic Density: A Systematic Review and Translational Appraisal for the Pathophysiology, Clinics, and Antipsychotics’ Treatment of Schizophrenia
title_fullStr Dysregulated Signaling at Postsynaptic Density: A Systematic Review and Translational Appraisal for the Pathophysiology, Clinics, and Antipsychotics’ Treatment of Schizophrenia
title_full_unstemmed Dysregulated Signaling at Postsynaptic Density: A Systematic Review and Translational Appraisal for the Pathophysiology, Clinics, and Antipsychotics’ Treatment of Schizophrenia
title_short Dysregulated Signaling at Postsynaptic Density: A Systematic Review and Translational Appraisal for the Pathophysiology, Clinics, and Antipsychotics’ Treatment of Schizophrenia
title_sort dysregulated signaling at postsynaptic density: a systematic review and translational appraisal for the pathophysiology, clinics, and antipsychotics’ treatment of schizophrenia
topic Systematic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954794/
https://www.ncbi.nlm.nih.gov/pubmed/36831241
http://dx.doi.org/10.3390/cells12040574
work_keys_str_mv AT debartolomeisandrea dysregulatedsignalingatpostsynapticdensityasystematicreviewandtranslationalappraisalforthepathophysiologyclinicsandantipsychoticstreatmentofschizophrenia
AT velluccilicia dysregulatedsignalingatpostsynapticdensityasystematicreviewandtranslationalappraisalforthepathophysiologyclinicsandantipsychoticstreatmentofschizophrenia
AT desimonegiuseppe dysregulatedsignalingatpostsynapticdensityasystematicreviewandtranslationalappraisalforthepathophysiologyclinicsandantipsychoticstreatmentofschizophrenia
AT mazzabenedetta dysregulatedsignalingatpostsynapticdensityasystematicreviewandtranslationalappraisalforthepathophysiologyclinicsandantipsychoticstreatmentofschizophrenia
AT baroneannarita dysregulatedsignalingatpostsynapticdensityasystematicreviewandtranslationalappraisalforthepathophysiologyclinicsandantipsychoticstreatmentofschizophrenia
AT ciccarellimariateresa dysregulatedsignalingatpostsynapticdensityasystematicreviewandtranslationalappraisalforthepathophysiologyclinicsandantipsychoticstreatmentofschizophrenia